News: Cancer Research

Next Page »« Previous Page

Regional variations in benign lung disease

Thursday, May 30th, 2013

By Dagny Stuart A study led by Vanderbilt University Medical Center investigators found that rates of benign lung disease diagnosis varied widely by state following surgery for lung cancer. The results could have an impact on clinical guidelines and health policy for lung cancer screening. The study was presented by Stephen A. Deppen, M.A., M.S., […]

Arteaga Leads New Cancer Initiatives

Friday, May 10th, 2013

Carlos L. Arteaga, M.D., professor of Medicine and Cancer Biology, has been appointed to a leadership role of two newly created cancer research initiatives at Vanderbilt-Ingram Cancer Center. He has been named the founding director of the Center for Cancer Targeted Therapies (CCTT) and director of the Vanderbilt-Ingram Cancer Center Research Network (VICCRN). The CCTT […]

Moses Receives Lifetime Achievement Award for Cancer Research

Wednesday, April 17th, 2013

Harold L. (Hal) Moses, M.D., professor of Medicine and Pathology, and professor and Acting Chair of Cancer Biology, and director emeritus of Vanderbilt-Ingram Cancer Center (VICC), has received the 10th Annual American Association for Cancer Research (AACR) Award for Lifetime Achievement in Cancer Research. He received the award April 7 during the AACR Annual Meeting […]

Arteaga Named AACR President-elect

Thursday, March 28th, 2013

Carlos L. Arteaga, M.D., professor of Medicine and Cancer Biology at Vanderbilt University School of Medicine, has been chosen president-elect for 2013-2014 of the American Association for Cancer Research. Arteaga, who holds the Donna S. Hall Chair in Breast Cancer, also serves as associate director for clinical research and director of the Breast Cancer Research […]

Prostate Cancer Study of Long-term Effects

Thursday, January 31st, 2013

A new study comparing outcomes among prostate cancer patients treated with surgery versus radiotherapy found differences in urinary, bowel and sexual function after short-term follow-up, but those differences were no longer significant 15 years after initial treatment. The study, led by first author Matthew Resnick, M.D., instructor in Urologic Surgery, Vanderbilt University Medical Center, was […]

Record Number Elected AAAS Fellows

Thursday, November 29th, 2012

Seventeen members of Vanderbilt University’s faculty have been elected fellows of the American Association for the Advancement of Science (AAAS) this year. This is the largest number of Vanderbilt fellows to be elected in a single year. Vanderbilt University now has 80 AAAS fellows among its current and emeritus faculty. Vanderbilt’s fellows are among 702 […]

Lung Cancer Research Gets Boost from Breathe Deep Events

Tuesday, November 13th, 2012

More Tennesseans are expected to die this year from lung cancer than any other form of cancer. Yet, lung cancer research receives far less funding than other forms of the disease. To address this funding disparity, the LUNGevity Foundation will host the second annual Breathe Deep 5-K race/walk event, Saturday, Nov. 17, in Nashville’s Centennial […]

Photo: Lung Cancer Partnership

Friday, September 28th, 2012

Caroline Nebhan, right, a fourth-year student in the M.D./Ph.D. training program, explains a cancer research experiment to advocates from the National Lung Cancer Partnership who toured Vanderbilt-Ingram Cancer Center during their recent meeting in Nashville. Nebhan, who works in the research laboratory of William Pao, M.D., Ph.D., is studying the effects of a specific cancer […]

Target Acquired for Aggressive Tumor

Friday, September 28th, 2012

Angiosarcoma, a rare, aggressive tumor that arises from cells that line blood vessels, has a mortality rate of around 80 percent. Because of their constant contact with the blood stream, these tumors can spread quickly and freely throughout the body. The INK4a/ARF locus on chromosome 9 – a region that encodes tumor suppressor proteins – […]

Grant Renewal Boosts GI Cancer Research Program

Friday, September 21st, 2012

Vanderbilt-Ingram Cancer Center’s gastrointestinal Specialized Program of Research Excellence (SPORE) has been awarded its third round of funding by the National Cancer Institute (NCI). “We decided to roll the dice and propose high-risk, high-reward projects,” said Robert Coffey Jr., M.D., Ingram Professor of Cancer Research, professor of Medicine and Cell and Developmental Biology, and director […]